Andrew Zolopa
Acting Chief of Infectious Diseases, Stanford University, School of Medicine · Stanford Health Care
Credentials: · ·
History
- Present
Stanford University Division · Stanford Health Care
- Present
- Present
Infectious Disease
Internal Medicine
Research
AIDS · 2000 · 818 citations
Non-adherence to highly active antiretroviral therapy predicts progression to AIDS
AIDS · 2001 · 769 citations
PLoS ONE · 2009 · First of 8 authors · Corresponding · 395 citations
25 papers · 14 as a fellow
21 papers
- DK
9 papers
9 papers
8 papers
- NS
8 papers
- WF
8 papers
- DI
7 papers
Grants
- 2007–2014
Stanford AIDS Clinical Trials Unit
National Institute of Allergy and Infectious Diseases · UM1
Contact PI · $1.3M · Stanford University
- 2007–2013
Stanford AIDS Clinical Trials Unit
National Institute of Allergy and Infectious Diseases · U01
Contact PI · $4.3M · Stanford University
- 2000–2008
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $1.1M · Stanford University
- 1986–2006
National Institute of Allergy and Infectious Diseases · U01
Contact PI · $4.5M · Stanford University
Clinical trials
- 2014–2016
Switch From Nevirapine-based Regimen to Once a Day Rilpivirine/Emtricitabine/Tenofovir
Principal investigator · Completed · Phase 2, Phase 3
Philip Grant
- 2009–2011
HIV Prevention and Care of Psychological Trauma in Vulnerable Rwandan Youth
Principal investigator · Completed
Stanford University
- 2007–2010
- 2005
The Switch Study: The Role of Lamivudine/Emtricitabine (3TC/FTC) in Antiretroviral Regimens
Principal investigator · Completed
Stanford University